Online citations, reference lists, and bibliographies.
← Back to Search

Nickel-quinolones Interaction. Part 1 - Nickel(II) Complexes With The Antibacterial Drug Sparfloxacin: Structure And Biological Properties.

Kalliopi C. Skyrianou, E. K. Efthimiadou, V. Psycharis, A. Terzis, D. P. Kessissoglou, G. Psomas
Published 2009 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The mononuclear nickel(II) complexes with the third-generation quinolone antibacterial agent sparfloxacin in the absence or presence of nitrogen donor heterocyclic ligands (1,10-phenanthroline or 2,2'-bipyridine) have been synthesized and characterized. The experimental data suggest that sparfloxacin acts as deprotonated bidentate ligand coordinated to Ni(II) ion through the ketone and carboxylato oxygens. The crystal structure of (1,10-phenanthroline)bis(sparfloxacinato) nickel(II), 2 has been determined by X-ray crystallography. The cyclic voltammograms of the complexes recorded in dmso solution and in 1/2 dmso/buffer (containing 150 mM NaCl and 15 mM trisodium citrate at pH 7.0) solution have shown that in the presence of CT DNA they can bind to CT DNA by the intercalative binding mode. UV study of the interaction of the complexes with calf-thymus DNA (CT DNA) has shown that the complexes can bind to CT DNA and 2 exhibits the highest binding constant to CT DNA. Competitive study with ethidium bromide (EB) has shown that the complexes can displace the DNA-bound EB indicating that they bind to DNA in strong competition with EB for the intercalative binding site. The antimicrobial activity of the complexes has been tested on three different microorganisms and has revealed that the inhibition provided by the complexes is slightly decreased in comparison to free sparfloxacin. The complexes exhibit good binding propensity to human and bovine serum albumin proteins having relatively high binding constant values.
This paper references
10.1016/J.JINORGBIO.2004.12.014
Effect of charge transfer bands on the photo-induced DNA cleavage activity of [1-(2-thiazolylazo)-2-naphtholato]copper(II) complexes.
S. Dhar (2005)
10.1021/IC700755P
Mixed-ligand copper(II)-phenolate complexes: effect of coligand on enhanced DNA and protein binding, DNA cleavage, and anticancer activity.
V. Rajendiran (2007)
10.1016/J.JPBA.2005.01.023
Fluorescence spectroscopic study of serum albumin-bromadiolone interaction: fluorimetric determination of bromadiolone.
S. Deepa (2005)
10.1016/S0162-0134(03)00179-X
Influence of copper(II) and magnesium(II) ions on the ciprofloxacin binding to DNA.
Petra Drevenšek (2003)
10.1016/J.JINORGBIO.2005.05.016
Synthesis, characterization, crystal structure and biological activity of a novel heterotetranuclear complex: [NiLPb(SCN)2(DMF)(H2O)]2, bis-{[mu-N,N'-bis(salicylidene)-1,3-propanediaminato-aqua-nickel(II)](thiocyanato)(mu-thiocyanato)(mu-N,N'-dimethylformamide)lead(II)}.
R. Kurtaran (2005)
10.1021/IC50111A039
Crystal and molecular structure of tris (1,10-phenanthroline)nickel(II) pentacarbonylmanganate(-I), [Ni(1,10-phen)3][Mn(CO)5]2
B. A. Frenz (1972)
10.1016/S0162-0134(02)00591-3
High nuclearity nickel compounds with three, four or five metal atoms showing antibacterial activity.
M. Alexiou (2003)
10.1128/AAC.48.2.608-611.2004
Replacement of ParC α4 Helix with That of GyrA Increases the Stability and Cytotoxicity of Topoisomerase IV-Quinolone-DNA Ternary Complexes
Emily S Pfeiffer (2004)
10.1016/S0162-0134(03)00123-5
Interactions of oxovanadium(IV) and the quinolone family member--ciprofloxacin.
I. Turel (2003)
10.1016/S0162-0134(01)00220-3
Synthesis, structure and biological activity of nickel(II) complexes of 5-methyl 2-furfural thiosemicarbazone.
E. M. Jouad (2001)
10.1016/j.jinorgbio.2007.12.011
Copper(II) complexes with sparfloxacin and nitrogen-donor heterocyclic ligands: Structure-activity relationship.
E. K. Efthimiadou (2008)
10.1016/0022-328X(88)83103-6
Comprehensive Coordination Chemistry
C. Eaborn (1988)
Comprehensive medicinal chemistry II
J. B. Taylor (2006)
10.1016/S0162-0134(98)10019-3
Dinuclear palladium(II) complexes containing two monofunctional [Pd(en)(pyridine)Cl]+ units bridged by Se or S. Synthesis, characterization, cytotoxicity and kinetic studies of DNA-binding.
G. Zhao (1998)
10.1016/J.ACTBIO.2005.07.002
New modulated metallic macrocycles: Electrochemistry and their interaction with calf thymus DNA.
S. Tabassum (2005)
10.1016/J.JINORGBIO.2005.03.017
Synthesis, characterization and DNA-binding properties of a new cobalt(II) complex: Co(bbt)2Cl2.
K. Jiao (2005)
New classification and update on the quinolone antibiotics.
D. King (2000)
10.1016/0165-6147(91)90535-Z
Comprehensive medicinal chemistry
H. Timmerman (1991)
10.1016/J.JINORGBIO.2006.06.001
DNA Binding and cleavage activity of Ni(II) complex with all-trans retinoic acid.
Yu-min Song (2006)
10.1016/S0020-1693(01)00375-9
Inclusion compounds containing a drug: structure and thermal stability of the first clathrates of nitrazepam and isothiocyanato ethanol complexes of Co(II) and Ni(II)
P. Bombicz (2001)
10.1021/BI00745A020
Quenching of fluorescence by oxygen. A probe for structural fluctuations in macromolecules.
J. Lakowicz (1973)
10.1016/S0162-0134(01)00210-0
Biological activity of complexes derived from thiophene-2-carbaldehyde thiosemicarbazone. Crystal structure of [Ni(C(6)H(6)N(3)S(2))(2)].
J. García-Tojal (2001)
10.5860/choice.44-3876
Principles of fluorescence spectroscopy
J. R. Lakowicz (1983)
10.1021/JA00018A019
Long-range fluorescence quenching of ethidium ion by cationic porphyrins in the presence of DNA
R. Pasternack (1991)
10.1016/J.JINORGBIO.2007.10.005
Synthesis, structure and interactions with DNA of novel tetranuclear, [Mn4(II/II/II/IV)] mixed valence complexes.
Anastasia Dimitrakopoulou (2008)
10.1016/J.JINORGBIO.2006.07.019
Structure and biological properties of the copper(II) complex with the quinolone antibacterial drug N-propyl-norfloxacin and 2,2'-bipyridine.
E. K. Efthimiadou (2007)
10.1016/J.JINORGBIO.2006.06.012
Synthesis, structure and biological activity of copper(II) complexes with oxolinic acid.
G. Psomas (2006)
10.1021/CR030101Q
Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents.
L. Mitscher (2005)
10.1016/J.POLY.2006.01.018
Low-temperature (100 K) crystal structures of pentaaqua(5-nitrosalicylato) complexes of magnesium(II), zinc(II), cobalt(II) and nickel(II) : A π-π stacked and hydrogen bonded 3D supramolecular architecture
G. Morgant (2006)
10.1016/S0277-5387(99)00049-2
Electrochemical synthesis of nickel(II) complexes of tosylamides: crystal structures of [(4-methylphenyl)sulfonyl]-imino-1H-pyridine], 2,2′-bipyridine bis{[(4-methylphenyl) sulfonyl]-2-pyridyl-amide}nickel(II) and 1,10-phenanthroline bis{[(4-methylphenyl) sulfonyl]-2-pyridyl-amide}nickel(II)
S. Cabaleiro (1999)
10.1021/JA00258A046
Voltammetric studies of the interaction of tris(1,10-phenanthroline)cobalt(III) with DNA
M. T. Carter (1987)
10.1016/J.JINORGBIO.2005.04.012
Nickel (II) complexes of naphthaquinone thiosemicarbazone and semicarbazone: synthesis, structure, spectroscopy, and biological activity.
Zahra Afrasiabi (2005)
10.1016/J.POLY.2006.05.010
Synthesis and spectrothermal studies of vitamin B13 complexes of cobalt(II) and nickel(II) with 4-methylimidazole: Crystal structure of [Ni(HOr)(H2O)(4-Meim)3]2 · 5H2O
O. Z. Yeşilel (2006)
10.1016/J.JLUMIN.2006.06.013
Interaction of the flavonoid hesperidin with bovine serum albumin: A fluorescence quenching study
Y. Wang (2007)
10.1016/j.jinorgbio.2009.03.007
Zinc complexes of the antibacterial drug oxolinic acid: structure and DNA-binding properties.
Alketa Tarushi (2009)
10.1016/S0162-0134(00)00132-X
DNA-binding and photocleavage studies of cobalt(III) polypyridyl complexes: [Co(phen)2IP]3+ and [Co(phen)2PIP]3+
Qian-ling Zhang (2001)
10.1016/J.JINORGBIO.2003.10.006
Synthesis, characterization and biological activity of Ni, Cu and Zn complexes of isatin hydrazones.
Maria C Rodríuez-Argüelles (2004)
10.1016/J.JPBA.2004.08.021
Study of the interaction between monoammonium glycyrrhizinate and bovine serum albumin.
Y. Hu (2004)
10.1016/j.jinorgbio.2008.05.012
Mononuclear metal complexes with ciprofloxacin: Synthesis, characterization and DNA-binding properties.
G. Psomas (2008)
10.1016/J.INOCHE.2006.12.016
Neutral dimeric copper–sparfloxacin conjugate having butterfly motif with antiproliferative effects against hormone independent BT20 breast cancer cell line
Dipti Shingnapurkar (2007)
10.1016/J.BMCL.2006.04.034
Crystal structure, spectroscopic, and biological study of the copper(II) complex with third-generation quinolone antibiotic sparfloxacin.
E. K. Efthimiadou (2006)
10.1016/j.bmcl.2008.05.115
Structure, antimicrobial activity and DNA-binding properties of the cobalt(II)-sparfloxacin complex.
E. K. Efthimiadou (2008)
10.1021/JA9734049
BINDING MODE OF NORFLOXACIN TO CALF THYMUS DNA
G. Son (1998)
10.1016/J.POLY.2007.04.031
Synthesis, characterization and interaction with DNA of mononuclear metal complexes with oxolinic acid
Alketa Tarushi (2007)
10.1016/S0162-0134(00)00131-8
Copper(II) complexes with phenoxyalkanoic acids and nitrogen donor heterocyclic ligands: structure and bioactivity.
C. Dendrinou-Samara (2001)
10.1016/J.POLY.2007.08.043
Synthesis, characterization and DNA-binding of the mononuclear dioxouranium(VI) complex with ciprofloxacin
G. Psomas (2008)
10.1021/JA00206A020
Voltammetric studies of the interaction of metal chelates with DNA. 2. Tris-chelated complexes of cobalt(III) and iron(II) with 1,10-phenanthroline and 2,2'-bipyridine
M. T. Carter (1989)
10.1021/AR00177A001
On demonstrating DNA intercalation
E. C. Long (1990)
10.1002/0470027320.s4104
Infrared and Raman Spectra of Inorganic and Coordination Compounds
K. Nakamoto (1978)
10.1021/jm7013259
Novel copper(II) complex of N-propyl-norfloxacin and 1,10-phenanthroline with enhanced antileukemic and DNA nuclease activities.
Maria E Katsarou (2008)
10.1016/J.JINORGBIO.2006.03.013
Neutral and cationic mononuclear copper(II) complexes with enrofloxacin: structure and biological activity.
E. K. Efthimiadou (2006)
10.1021/JA00847A045
Letter: Jack bean urease (EC 3.5.1.5). A metalloenzyme. A simple biological role for nickel?
N. E. Dixon (1975)
10.1016/J.BMCL.2005.11.065
Isothiazoloquinolones containing functionalized aromatic hydrocarbons at the 7-position: synthesis and in vitro activity of a series of potent antibacterial agents with diminished cytotoxicity in human cells.
J. A. Wiles (2006)
10.1016/S0162-0134(01)00408-1
Thiourea derivatives and their nickel(II) and platinum(II) complexes: antifungal activity.
R. del Campo (2002)
10.1021/JA01640A067
A Further Examination of the Molecular Weight and Size of Desoxypentose Nucleic Acid
M. Reichmann (1954)
10.5860/choice.44-4794
Meyler's side effects of drugs : the international encyclopedia of adverse drug reactions and interactions
J. Aronson (2006)
10.1016/S0010-8545(02)00027-9
The interactions of metal ions with quinolone antibacterial agents
I. Turel (2002)
Comprehensive Coordination Chemistry II
J. Mccleverty (2004)
10.1093/NAR/13.17.6017
A study of the interactions of some polypyridylruthenium (II) complexes with DNA using fluorescence spectroscopy, topoisomerisation and thermal denaturation.
J. Kelly (1985)
10.1016/S0162-0134(02)00487-7
Interactions of metal ions with two quinolone antimicrobial agents (cinoxacin and ciprofloxacin). Spectroscopic and X-ray structural characterization. Antibacterial studies.
M. P. López-Gresa (2002)
10.1016/S0022-2836(61)80047-8
A procedure for the isolation of deoxyribonucleic acid from micro-organisms
J. Marmur (1961)
SADABS, Program for Empirical Absorption Correction of Area Detector Data
G. M. Sheldrick (1996)



This paper is referenced by
10.1007/s12010-014-1450-9
Metal Complex of the First-Generation Quinolone Antimicrobial Drug Nalidixic Acid: Structure and Its Biological Evaluation
Anamika Debnath (2014)
10.1111/cbdd.12071
A New Approach to Counteract Bacteria Resistance: A Comparative Study Between Moxifloxacin and a New Moxifloxacin Derivative in Different Model Systems of Bacterial Membrane
S. C. Lopes (2013)
10.1016/j.jinorgbio.2020.111019
Transition metal complexes with a novel guanine-based (E)-2-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazolin-4(3H)-one: Synthesis, characterization, interaction with DNA and albumins and antioxidant activity.
Marialena Lazou (2020)
10.1016/J.MOLSTRUC.2018.12.109
Synthesis & crystal structures of four new biochemical active Ni(II) complexes of thiosemicarbazone and isothiosemicarbazone-based ligands: In vitro antimicrobial study
Alireza Akbari (2019)
10.1080/00958972.2017.1293821
Synthesis, crystallographic and spectroscopic studies, evaluation as antimicrobial and cytotoxic agents of a novel mixed-ligand nickel(II) complex
S. Abdolmaleki (2017)
10.1002/AOC.4150
Supramolecular interaction of transition metal complexes with albumins and DNA: Spectroscopic methods of estimation of binding parameters
Polina А. Galkina (2018)
10.1039/C4RA11682H
Structure, antimicrobial activity, albumin- and DNA-binding of manganese(II)-sparfloxacinato complexes†
Marianthi Zampakou (2015)
10.1002/JCCS.201000099
High-Performance Liquid Chromatography Assay for Moxifloxacin in Bulk, Pharmaceutical Formulations and Serum: Application to In-Vitro Metal Interactions
N. Sultana (2010)
10.1016/j.jinorgbio.2010.03.017
Solution and biological behaviour of enrofloxacin metalloantibiotics: a route to counteract bacterial resistance?
Raúl G. Saraiva (2010)
Spectroscopic and cytotoxic studies of losartan complexes.
Mansoor Ahmed (2018)
10.1016/J.MOLSTRUC.2014.03.052
Synthesis, structure, and properties of Cd(II) complexes generated from 2-phenylquinoline derivatives
N. Lei (2014)
10.1007/s12039-014-0597-9
Cytotoxic, DNA binding, DNA cleavage and antibacterial studies of ruthenium–fluoroquinolone complexes
M. Patel (2014)
10.1016/J.ICA.2015.06.001
Two novel 2D waves copper(II) coordination polymer with the quinolone antimicrobial drugs ciprofloxacin: Synthesis, structure and biological evaluation
J. Li (2015)
10.1016/j.saa.2010.11.018
Spectroscopic studies on the interaction between Pr(III) complex of an ofloxacin derivative and bovine serum albumin or DNA.
Min Xu (2011)
10.1007/s12039-016-1111-3
Synthesis, crystal structure, thermal and theoretical studies of bis(N-ethyl-N-phenyldithiocarbamato) Ni(II) and (N-ethyl-N-phenyldithiocarbamato) (isothiocyanato) (triphenylphosphine) Ni(II)
D. Onwudiwe (2016)
10.1039/C7NJ00402H
Luminescent closed shell nickel(II) pyridyl-azo-oximates and the open shell anion radical congener: molecular and electronic structure, ligand redox behaviour and biological activity
Shuvam Pramanik (2017)
10.1039/C5RA05308K
Cobalt(II) complexes with the quinolone antimicrobial drug oxolinic acid: structure and biological perspectives
Evgenia P. Irgi (2015)
10.1080/07391102.2020.1804454
Investigation of biological activity of nickel (II) complex with naproxen and 1,10-phenanthroline ligands.
Zeinab Mirzaei-Kalar (2020)
10.1007/s11243-016-0085-9
Effect of auxiliary ligand on the crystalline architectures of copper(II)-sparfloxacin complexes via coordinative and supramolecular interactions
X. Zhang (2016)
Fluoroquinolone Transport Through Bacterial Membranes: A Multi-Technique Approach
Carla F Sousa (2014)
10.1002/CHIN.201512297
Synthesis and Biological Activities of Selected Quinolone-Metal Complexes
R. Singh (2013)
10.21608/ejchem.2012.1128
S Synthesis , Characterization , Spectrofluorometric and Antibacterial Activity Studies of Moxifloxacin-Zirconium Complex
Basma (2014)
10.1002/AOC.2919
Interactions with herring sperm DNA and biological studies of sparfloxacin drug-based copper(II) compounds
M. Patel (2012)
10.1016/j.jinorgbio.2014.05.007
Fluoroquinolone-metal complexes: a route to counteract bacterial resistance?
M. Feio (2014)
10.1016/J.POLY.2013.07.028
Synthesis, crystal structure and antifungal activity of a Ni(II) complex of a new hydrazone derived from antihypertensive drug hydralazine hydrochloride
E. Nfor (2013)
10.1016/j.jinorgbio.2015.01.009
Synthesis, structure and biological activity of nickel(II) complexes with mefenamato and nitrogen-donor ligands.
Xanthippi Totta (2015)
10.1080/07391102.2018.1512420
Supramolecular complex binding to G-quadruplex DNA: Berberine encapsulated by a planar side arm–tethered β-cyclodextrin
S. Suganthi (2018)
10.1039/c6dt00915h
Synthesis, structure, and biological evaluation of a copper(ii) complex with fleroxacin and 1,10-phenanthroline.
Y. Xiao (2016)
10.1155/2018/8478152
Synthesis, Structure, DNA Interaction, and SOD Activity of Three Nickel(II) Complexes Containing L-Phenylalanine Schiff Base and 1,10-Phenanthroline
Peiran Zhao (2018)
10.1016/J.POLY.2016.05.044
Nickel(II) complexes of flufenamic acid: Characterization, structure and interaction with DNA and albumins
Christina Tserkezidou (2016)
Synthesis of quinolone derivatives and their molecular docking for antiepileptic activity
Alka Pradhan (2020)
10.1007/s00044-010-9486-z
DNA binding and cleavage by dinuclear nickel(II) complexes with neutral bidentate ligands and ciprofloxacin
M. Patel (2010)
See more
Semantic Scholar Logo Some data provided by SemanticScholar